arrow
A

Albert C. Koong

The University of Texas MD Anderson Cancer Center
H指数:88
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A transferable gut microbiota–bile acid pathway programs nanomedicine pharmacokinetics and therapeutic response

一种可转移的肠道菌群-胆汁酸通路程序纳米药物动力学和治疗反应

2026-07-310
PRE
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response

放疗后肝内胆管癌增强变化的可测量影像学改变反映了反应的物理机制

2025-12-120
OAAI
Safety and efficacy of liver-directed radiotherapy after chemoimmunotherapy for advanced cholangiocarcinoma: an early report from a large tertiary cancer center
2025-10-310
PRE
Endoscopic Ultrasound-Guided Injection of NBTXR3 Activated by Radiotherapy With Concurrent Chemotherapy for Esophageal Adenocarcinoma: Interim Analysis of Feasibility and Safety

内镜超声引导下NBTXR3注射联合放疗激活并同步化疗治疗食管腺癌:可行性与安全性中期分析

2025-10-010
PRE
Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance

放射疗法促进铜死亡,并与铜死亡诱导剂协同作用以克服肿瘤放射抗性

2025-04-100
OA
A comprehensive spatial atlas of neoadjuvant chemoradiation therapy in resected pancreatic cancer identifies cellular & microenvironmental determinants of persister populations
2024-09-150
PRE
Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1 (vol 133, e168277, 2023)
2024-08-150
OAAI
Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volume
2024-05-102
OAAI
Implementation and Ef fi cacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network
2024-05-012
PRE
Synthetic cationic helical polypeptides for the stimulation of antitumour innate immune pathways in antigen-presenting cells
2024-04-193
OA
Phase I study of endoscopic ultrasound (EUS)-guided NBTXR3 delivery activated by radiotherapy (RT) for locally advanced or borderline resectable pancreatic cancer (LAPC or BRPC)
2024-01-160
PRE